Medicare Enrolled

Dr. Madhav Suri, M.D.

Optician · Fresno, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
7151 N CEDAR AVE, Fresno, CA 93720
5593227766
In practice since 2005 (20 years)
NPI: 1669456539 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Suri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Suri? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Suri

Dr. Madhav Suri is an optician specialist in Fresno, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Suri performed 2,276 Medicare services across 1,389 unique beneficiaries.

Between the years covered by Open Payments, Dr. Suri received a total of $11,463 from 54 pharmaceutical and/or device companies across 606 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Suri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 34% volume in CA $11,463 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,276
Medicare services
Top 34% in CA for optician
1,389
Unique beneficiaries
$180
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~114 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
860 $78 $234
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
378 $95 $185
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
201 $116 $270
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
191 $143 $450
Video EEG monitoring, 12-26 hours
Continuous monitoring of brain wave activity combined with video recording for 12 to 26 hours.
130 $921 $1,485
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
115 $365 $699
EEG monitoring, 12-26 hours
This procedure involves monitoring brain wave activity using an electroencephalogram (EEG) for a duration of 12 to 26 hours.
99 $247 $874
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
94 $236 $750
Continuous EEG brain wave monitoring
A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously.
55 $208 $635
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
52 $107 $350
Prolong video EEG monitoring, over 84 hours
Continuous recording of brain wave activity combined with video for more than 84 hours, including professional review and reporting.
31 $305 $660
EEG brain wave test, 61-119 minutes
This procedure measures electrical activity in the brain using electrodes placed on the scalp. It records brain wave patterns for a duration between 61 and 119 minutes.
31 $361 $765
Prolong EEG monitoring, over 84 hours
This procedure involves continuous recording of brain wave activity for more than 84 hours, followed by a professional review and report of the results.
24 $212 $565
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
15 $317 $625
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,463
Total received (2018-2024)
Avg $1,638/year across 7 years
Top 13% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
606
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,226 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$237 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,391
2023
$1,324
2022
$1,084
2021
$1,430
2020
$1,757
2019
$3,370
2018
$1,107

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$761
PFIZER INC.
$166
Eisai Inc.
$118
Nalu Medical, Inc.
$59
UCB, Inc.
$53
NEUROPACE, INC.
$45
SCILEX PHARMACEUTICALS INC.
$40
Medtronic, Inc.
$36
Lundbeck LLC
$27
Biogen, Inc.
$25
Otsuka America Pharmaceutical, Inc.
$23
Philips North America LLC
$23
Azurity Pharmaceuticals, Inc.
$15
Top 3 companies account for 75.2% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,125
Teva Pharmaceuticals USA, Inc.
$917
AbbVie Inc.
$914
UCB, Inc.
$902
LivaNova USA, Inc.
$826
Novartis Pharmaceuticals Corporation
$532
Amgen Inc.
$468
Lilly USA, LLC
$437
Sunovion Pharmaceuticals Inc.
$390
Supernus Pharmaceuticals, Inc.
$388
PFIZER INC.
$355
Kyowa Kirin, Inc.
$347
Eisai Inc.
$329
SK Life Science, Inc.
$290
Allergan, Inc.
$276
Akcea Therapeutics, Inc.
$250
Lundbeck LLC
$213
Avanir Pharmaceuticals, Inc.
$209
EISAI INC.
$190
Alexion Pharmaceuticals, Inc.
$172
Neurelis, Inc.
$158
E.R. Squibb & Sons, L.L.C.
$136
Horizon Therapeutics plc
$123
Greenwich Biosciences, Inc.
$122
ARBOR PHARMACEUTICALS, INC.
$119
Biohaven Pharmaceutical Holding Company Ltd.
$102
Assertio Therapeutics, Inc.
$98
Amneal Pharmaceuticals LLC
$91
Celgene Corporation
$87
Biohaven Pharmaceuticals, Inc.
$74
NEUROPACE, INC.
$71
Sumitomo Pharma America, Inc.
$64
Nalu Medical, Inc.
$59
NOVARTIS PHARMACEUTICALS CORPORATION
$52
Zyla Life Sciences
$50
Otsuka America Pharmaceutical, Inc.
$48
Almatica Pharma LLC
$47
Upsher-Smith Laboratories LLC
$42
SCILEX PHARMACEUTICALS INC.
$40
Catalyst Pharmaceuticals, Inc.
$38
Medtronic, Inc.
$36
Impax Laboratories, Inc.
$30
Biogen, Inc.
$25
Alnylam Pharmaceuticals Inc.
$24
Strongbridge US INC.
$23
Philips North America LLC
$23
AstraZeneca Pharmaceuticals LP
$22
AQUESTIVE THERAPEUTICS, INC.
$22
Zogenix Inc.
$20
Ultragenyx Pharmaceutical Inc.
$20
Boston Scientific Corporation
$20
ASSERTIO THERAPEUTICS, Inc.
$17
Azurity Pharmaceuticals, Inc.
$15
Mitsubishi Tanabe Pharma America, Inc.
$14
Top 3 companies account for 25.8% of all-time payments
Associated products mentioned in payments ›
(6346) Intrasight Mobile · AFINITOR · AIMOVIG · AJOVY · APTIOM · AUSTEDO · Aimovig · BOTOX · BRILINTA · Briviact · CAMBIA · COMIRNATY · Cambia · Cenobamate · EMGALITY · Epidiolex · FYCOMPA · Fintepla · Fycompa · GENERAL - DBS · GILENYA · GRALISE · Gralise · HORIZANT · Horizant · KEVEYIS · KRYSTEXXA · LEQEMBI · Leqembi · NAPRELAN · NOURIANZ · NUEDEXTA · NURTEC ODT · Nalu Neurostimulation System · Neupro · Nourianz · Nuedexta · ONFI · ONPATTRO · OXTELLAR XR · PAXLOVID · PERCEPT PC BRAINSENSE · QULIPTA · REYVOW · RNS Neurostimulator Kit · RNS System · RYTARY · Radicava · SOLIRIS · SPRIX · SYMPAZAN · Strensiq · TEGSEDI · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · UBRELVY · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VYEPTI · Vimpat · XCOPRI · ZEPOSIA · ZORVOLEX · ZTLido · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in Fresno?
Compare opticians in the Fresno area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
94
Per 100K population
9.3
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Suri is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 13% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Suri experienced with electromyography of arm or leg muscles?
Based on Medicare claims data, Dr. Suri performed 860 electromyography of arm or leg muscles services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Suri receive payments from pharmaceutical companies?
Yes. Dr. Suri received a total of $11,463 from 54 companies across 606 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Suri's costs compare to other opticians in Fresno?
Dr. Suri's average Medicare payment per service is $180. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Suri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →